化学物质(药物)毒性数据库(Chemical Toxicity Database)--->在线检索
- 3091 I.S.
- 309 F
- 3082 I.S.
- 3081 I.S.
- 308 FC
- 3079 I.S.
- 3071 I.S.
- 3070 I.S.
- 307 FC
- 3060 I.S.
- 306 FC
- 305CE
- 3042 I.S.
- 3039 I.S.
- 3037 I.S.
- 3034 I.S.
- 3026 C.B.
- 3025 C.B.
- 3024 Cerm
- 3023 I.S.
- 3022 I.S.
- 301C47
- 3015 R.P.
- 3013 I.S.
- 3012 I.S.
- 3011 I.S.
- 3010 I.S.
- 300C47
- 300-A-B-C
- 3008-B
- 3008B
- 3007 I.S.
- 30038CM
- 3003 I.S.
- 300 C
- 300 B
- 300 A
- 30-(2,10-Bis(sulfooxy)undecyl)-16,18-bis(sulfooxy)oxacyclotriacont-3-en- 2-one
- 3:5:3':5'-Tetraiodo-D-thyronine sodium
- 3:4-Dimethylene-1:2-benzanthracene
- 3.697 R.P.
- 3.5. Dimethylpyrazol 4-carbonsaeureaethyl ester
- 3.5. Dimethylpyrazol 4-acetyl-4-carbonsaeureaethylester
- 3.381 R.P.
- 3.1 Oil
- 3,A-T
- 3,9-Perylene, 1,2,6b,7,8,12b-hexahydro-1,4,6b,10-tetrahydroxy-, (1-alpha,6b-beta,12b-beta)-
- 3,9-Fluoranthenedicarboxylic acid , bis(3-(diethylamino)propyl) ester, dihydrochloride
- 3,9-Epoxy-3H-azirino(2,3-c)benzazocine-5-carboxaldehy de, 1-acetyl-7,9-bis(acetyloxy)-8-((( aminocarbonyl)oxy)methyl)-1,1a,2,8,9,9a-hexahydro-, (1a-alpha,3-alpha,8-alpha,9- alpha,9a-alpha)-
- 3,9-Epoxy-3H-azirino(2,3-c)(1)benzazocine-5-carboxald ehyde, 1,1a,2,8,9,9a-hexahydro- 8-(((aminocarbonyl)oxy)methyl)-7,9-dihydroxy-
- 3,9-Epoxy-3H-azirino(2,3-c)(1)benzazocine-5,8-dimetha nol, 1,1a,2,8,9,9a-hexahydro-7,9- dihydroxy-, alpha(8)-carbamate
- 3,9-Divinylspirobi(m-dioxane)
- 3,9-Divinyl-2,4,8,10-tetraoxaspiro(5.5)undecane
- 3,9-Dioxo-2H-indeno(2,1-c)pyridazine
- 3,9-Dinitrofluoranthene
- 3,9-Dimethylthiazolo(3,2-a)benzimidazolium iodide
- 3,9-Dimethylfluorene
- 3,9-Dimethylbenz(a)anthracene
- 3,9-Dimethyl-7-phenyl-1,2,3,4,4a,5-hexahydropyrazino(1,2-a)(1,4)benzodia zepin dihydrochlorid
- 3,9-Dimethyl-6-(phenylmethyl)-6,9-dihydro-5H-1,2,4-triazolo(3,4-i)purin- 5-one
- 3,9-Dimethyl-3,9-diazabicyclo(3.3.1)nonane dihydrochloride
- 3,9-Dimethyl-3,9-diazabicyclo(3,3,1)nonane methiodide
- 3,9-Dimethoxy-13a-alpha-berbine-2,10-diol
- 3,9-Dihydroxy-benzanthrone
- 3,9-Dihydroxybenz(a)anthracene
- 3,9-Dihydroxy-7-methylbenz(a)anthracene
- 3,9-Dihydroxy-7H-benz(de)anthracen-7-one
- 3,9-Dihydroxy-7,12-dimethylbenz(a)anthracene
- 3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one
- 3,9-Dihydroxy-5,6,6a-alpha,6b-beta,11,12,12a-beta,12b-alpha-octahydrodib enzo(a,g)biphenylene
- 3,9-Dihydroxy-12-methylbenz(a)anthracene
- 3,9-Dihydro-9-cyclopentyl-6H-purin-6-one
- 3,9-Dihydro-9-cyclohexyl-6H-purine-6-thione
- 3,9-Dihydro-9-cyclohexyl-6H-purin-6-one
- 3,9-Dihydro-9-butyl-6H-purin-6-one
- 3,9-Dihydro-8-methoxy-9-methyl-2-(1-methylethyl)furo(2,3-b)quinolin-4(2H )-one
- 3,9-Dihydro-2-(1-hydroxy-1-methylethyl)-8-methoxy-9-methylfuro(2,3-b)qui nolin-4(2H)-one
- 3,9-Diethyl-tridecyl-6-sulfate
- 3,9-Dicyclohexyl-2,3,4,8,9,10-hexahydronaphtho(1,2-e:5,6-e')bis(1,3)oxaz ine
- 3,9-Dibromobenzanthrone
- 3,9-Dibromo-7H-benz(de)anthracen-7-one
- 3,9-Dibrombenzanthrone
- 3,9-Diazaspiro(5.5)undecane-2,4-dione, 9-benzyl-3-(2-(3-indolyl)ethyl)-
- 3,9-Diazaspiro(5.5)undecane, 3,9-bis(2,3-epoxypropyl)-
- 3,9-Diazabicyclo(3.3.1)nonane, 9-methyl-, dihydrochloride
- 3,9-Diazabicyclo(3.3.1)nonane, 3-methyl-9-propionyl-
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-methyl-, dihydrochloride
- 3,9-Diazabicyclo(3.3.1)nonane, 3,9-dimethyl-, dihydrochloride
- 3,9-Diazabicyclo(3.3.1)nonane, 9-methyl-3-(3-piperidinopropyl)-, trihydrochloride
- 3,9-Diazabicyclo(3.3.1)nonane, 3-cinnamyl-9-propionyl-
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(3-piperidinopropyl)-, hydrochloride, hydrate (1:3:3)
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(3-morpholinopropyl)-, hydrochloride, hydrate (1:3:3)
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(3-(dimethylamino)propyl)-, hydrochloride, hydrate (1:3:3)
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(3-(diethylamino)propyl)-, hydrochloride, hydrate (1:3:3)
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(2-piperidinopropyl)-, trihydrochloride, hydrate
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(2-piperidinoethyl)-, dihydrochloride
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(2-morpholinopropyl)-, hydrochloride, hydrate (1:3:3)
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(2-morpholinoethyl)-, hydrochloride, hydrate (1:3:3)
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(2-(dimethylamino)propyl)-, hydrochloride, hydrate (1:3:2)
- 3,9-Diazabicyclo(3.3.1)nonane, 3-benzyl-9-(2-(dimethylamino)ethyl)-, dihydrochloride
[前一页][6198][6199][6200][6201][6202][后一页] 在线检索